CohBar, Inc. to Hold 2016 Annual Shareholder Meeting and Investor Update June 14, 2016
MENLO PARK, Calif.--(BUSINESS WIRE)-- CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, is hosting its Annual Shareholder Meeting on June 14, 2016.
Details for the Annual Shareholder Meeting:
Date: June 14, 2016
Time: 12:30 p.m. (Pacific Time)
Live Webcast: http://www.virtualshareholdermeeting.com/COB16.
Following the Annual Shareholder Meeting, CohBar will host a conference call and WebEx slide presentation to provide a corporate update for investors.
Details for the Investor Call and WebEx:
Date: June 14, 2016
Time: 1:00 p.m. (Pacific Time)
Audio, Dial-in U.S. and Canada: (888) 438-5525
Audio, Dial-in International: (719) 325-2244
Conference ID# 6467126
Slide Presentation, WebEx: https://meetings.webex.com/collabs/#/meetings/detail?uuid=M98K2AJJXGEUOJEQHWSJGF5MMJ-7UA1&rnd=861728.59576
For individuals participating in the Investor Call and WebEx, we request you please call into the audio and log into WebEx approximately 5-10 minutes before the 1 p.m. PT start of the presentation so that we can begin promptly.
CohBar (OTCQX: CWBR and TSXV: COB.U) is a leader in the research and development of mitochondria-based therapeutics, an emerging class of drugs for the treatment of diseases associated with aging. MBTs originate from the discovery of a novel group of peptides within the genome of mitochondria, the powerhouses of the cell. This groundbreaking discovery was made by our founders, world leaders in the biology of aging, metabolism and mitochondrial genomics. MBTs offer the potential to address a broad range of diseases such as type 2 diabetes, cancer, atherosclerosis and neurodegenerative disorders.
For additional company information, please visit www.cohbar.com.
Source: CohBar, Inc.
Released May 31, 2016